Expression of Ikaros Isoform 6 in Chinese Children With Acute Lymphoblastic Leukemia

Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia

(2010) P. Stow et al.   BLOOD

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL

(2010) R P Kuiper et al.   LEUKEMIA

Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia

(2009) Charles G. Mullighan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method

(2008) I. Iacobucci et al.   HAEMATOLOGICA

Acute lymphoblastic leukaemia

(2008) Ching-Hon Pui et al.   LANCET

Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels

(2008) Gen Kano et al.   LEUKEMIA & LYMPHOMA

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

(2008) Charles G. Mullighan et al.   NATURE

The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China

(2008) Xue-Qun Luo et al.   PEDIATRIC BLOOD & CANCER

High-risk childhood acute lymphoblastic leukemia in China: Factors influencing the treatment and outcome

(2008) Xue-Qun Luo et al.   PEDIATRIC BLOOD & CANCER